Free Republic 2nd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $83,401
94%  
Woo hoo!! And now less than $4.6k to go!! We can do this. Thank you all very much! God bless.

Keyword: pharma

Brevity: Headers | « Text »
  • RE: If you eat THIS, you're growing deadly tumors!

    05/19/2018 6:49:30 AM PDT · by JimRed · 133 replies
    email inbox ^ | today | unknown
    Are you literally FEEDING cancer cells by putting this one food on your dinner plate? This is important. You must stop eating this food today or you could be growing cancer cells. Now here's where it gets really interesting... As soon as you STOP eating it, the opposite happens: Cancer cells STARVE to death -- and die out by the thousands. Skeptical? See the proof here.
  • Amgen’s new migraine drug will cost 30 percent less than Wall Street expected

    05/19/2018 1:00:46 AM PDT · by GonzoII · 13 replies
    Stat News ^ | May 17, 2018 | Damian Garde
    Amgen will charge $6,900 a year for a new drug that can spare migraine sufferers a few headaches each month, a price that comes in well below Wall Street expectations as the company hopes to avoid the payer backlash that has hamstrung recent drug launches. ....snip At $6,900 a year, Aimovig would seem more likely to appease payers, but Amgen’s investors may question just how lucrative the drug will end up being. By 2019, there could be four competing migraine treatments on the market, creating a competitive environment that might force Amgen to aggressively discount its therapy to stay in...
  • Trump denounces ‘middlemen,’ largely spares pharma in drug pricing speech

    05/14/2018 6:05:40 PM PDT · by spintreebob · 21 replies
    http://www.modernhealthcare.com/article/20180511/NEWS/180519968 https://www.statnews.com/2018/05/11/trump-drug-pricing-speech/ https://www.scientificamerican.com/article/trump-denounces-middlemen-and-largely-spares-pharma-in-drug-pricing-speech/ http://www.bipc.com/trump-condemns-middlemen-in-drug-pricing-speech-modern-healthcare https://www.washingtonpost.com/news/powerpost/paloma/the-health-202/2018/05/14/the-health-202-health-industry-appears-unfazed-by-trump-s-drug-pricing-speech/5af4ac5530fb042588799464/ http://www.healthleadersmedia.com/health-plans/eliminating-middlemen-trump-takes-aim-pbms-drug-pricing-speech http://www.bipc.com/trump-condemns-middlemen-in-drug-pricing-speech-modern-healthcare
  • As Trump Prepares Plan to Lower Drug Prices, Big Pharma Girds for a Fight

    05/06/2018 4:48:11 PM PDT · by Theoria · 38 replies
    The New York Times ^ | 06 May 2018 | Robert Pear
    In his State of the Union address in January and again in New Hampshire in March, President Trump made a bold promise: “You’ll be seeing drug prices falling very substantially in the not-too-distant future,” he said, “and it’s going to be beautiful.” Not if the pharmaceutical companies can stop it. Big Pharma is pouring money into a lobbying campaign to thwart any serious efforts to rein in prescription drug prices ahead of a presidential speech this month where Mr. Trump plans to lay out his drug pricing proposals. “There is apprehension across the industry,” said Bruce Artim, who retired recently...
  • Menendez's Republican challenger: 'I'm offended' by senator's actions

    02/16/2018 3:47:33 PM PST · by GuavaCheesePuff · 18 replies
    Newark Star-Ledger ^ | February 13, 2018 | Brent Johnson
    Republican Bob Hugin wasted little time Tuesday in attacking U.S. Sen. Robert Menendez, the Democrat he's aiming to topple in this year's Senate race in New Jersey. "This campaign is going to be a contrast -- a stark contrast in candidates," Hugin, a multimillionaire former pharmaceutical executive, said minutes after formally announcing his bid for the seat currently held by Menendez, a two-term senator who recently saw federal corruption charges against him dropped. "I am offended by Senator Menendez's actions," Hugin, 63, told the crowd at the Springfield Elks Lodge. "He's violated the public trust and, at the same time,...
  • HIV breakthrough as cancer drug could hold secret to curing the virus

    12/01/2017 6:12:44 AM PST · by Red Badger · 27 replies
    www.mirror.co.uk ^ | 00:05, 1 DEC 2017 Updated10:52, 1 DEC 2017 | ByAmy-Clare Martin
    Doctors using a treatment called nivolumab on a lung cancer patient with Aids noticed a “drastic and persistent” decrease in infected white blood cells A new cancer drug could “cure” HIV, a revolutionary study suggests. Doctors using a treatment called nivolumab on a lung cancer patient with Aids noticed a “drastic and persistent” decrease in infected white blood cells. The findings have raised hopes that drugs could one day eradicate the HIV virus, which attacks the immune system and cur­­rently has no cure. At present, those infected must take anti-HIV drugs for the rest of their lives to stop the...
  • Amazon in talks with PBMs over pharma supply chain

    09/21/2017 2:12:13 AM PDT · by buckalfa · 25 replies
    Beckers Hospital Review ^ | September 20, 2017 | Mackenzie Bean
    Amazon is reportedly communicating with pharmacy benefit managers about potential drug contracts, according to a Leerink Partners analysis cited by CNBC. Amazon has been hiring more healthcare leaders and expanding its drug and medical supply distribution in recent months, spurring rumors the online retailer is stepping into the pharmacy business. The company may "indeed be in conversations with some middle-market PBMs now, in an effort to get into various contract arrangements," the Leerink analysis states, adding that Amazon could pose a "bigger threat" to the pharmaceutical industry than many individuals expect. However, it could take 18 months to 24 months...
  • Reporter Investigating Hillary Clinton Links To Russia Found Dead

    09/10/2017 5:45:20 AM PDT · by gaggs · 59 replies
    A Pulitzer Prize Winning Wall Street Journal Reporter who asked Russia for Information on Hillary Clinton was found dead 2 days later. Wall Street Journal writer/reporter Joseph Rago was found dead in his apartment on July 20th 2017. He was reportedly investigating Hillary’s involvement in the purchase of Russian drug company Veropharm by Abbot Labs at a time in 2014 when sanctions against Russia would have prevented the sale.
  • Jail Them All (Pharmaceutical Fraud)

    07/20/2017 5:44:40 AM PDT · by Wolfie · 85 replies
    Market Ticker ^ | July 20, 2017 | Karl Denninger
    Jail Them All There is no greater scam in the world today than the blatant and outrageous lies told to everyone from school age onward over the last 40+ years when it comes to diet, exercise, health and various risk factors associated with same. The root of the scam goes back even further, but it really became evident with the so-called "food pyramid" which emphasized refined starches (breads and "white vegetables") and claimed that fats were bad for you and should be limited. Then, the scam evolved. Only saturated fats were bad, so it was claimed. The rest weren't so...
  • Dangerously Addictive Painkiller Patients Who Shouldn’t Have Received It, Says Whistleblower: SUBSY

    06/05/2017 5:11:43 AM PDT · by GailA · 37 replies
    NBCnews ^ | 5/5/17 | Corky Siemaszko
    This DRUG is being used OFF LABEL and KILLS, fueling the FAKE Opioid Crisis. PIG PHARMA pushed. It's called Subsys and it's a painkiller 100 times more powerful than morphine that was approved by the FDA for cancer patients whose agony can't be relieved by other narcotics alone.
  • PINKERTON: A New Vision for Big Pharma and for the American Patient in the Trump Era

    02/22/2017 4:47:54 AM PST · by davikkm · 13 replies
    breitbart ^ | JAMES P. PINKERTON
    First of Four Parts… The Pharma Companies In the Crosshairs During last year’s presidential campaign, candidate Donald Trump said that if elected, he would save the federal government billions by forcing the pharmaceutical companies to negotiate—that is, lower—their prices. On January 11, 2017, President-elect Trump said that the pharma companies were “getting away with murder” in their pricing, and reiterated his demand for new competition policies aimed at bringing down costs. On January 31, President Trump met face-to-face with top executives and offered a more nuanced exposition of his thinking. First, he reiterated his oft-expressed point about the value of...
  • Sharp Rise Reported in Older Americans’ Use of Multiple Psychiatric Drugs

    02/13/2017 10:12:01 AM PST · by MarvinStinson · 51 replies
    NY TIMES ^ | FEB. 13, 2017 | BENEDICT CAREYFEB.
    <p>The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, researchers reported on Monday.</p> <p>The new analysis, based on data from doctors’ office visits, suggests that inappropriate prescribing to older people is more common than previously thought. Office visits are a close, if not exact, estimate of underlying patient numbers. The paper appears in the journal JAMA Internal Medicine.</p>
  • Trump opens can of worms with blast at drugmakers

    01/13/2017 6:19:27 AM PST · by GIdget2004 · 72 replies
    The Hill Extra ^ | 01/13/2017 | RACHEL ROUBEIN AND SARAH CHACKO
    President-elect Donald Trump reopened an awkward division over high drug prices with fellow Republicans during his first press briefing this week -- putting lawmakers on defense on an issue they've tried to tamp down. GOP lawmakers reacted in a way they've become accustomed to over the past year: Sorry, but we haven't seen his comments. Yet, Trump's call to "create new bidding procedures for the drug industry" puts Republicans in a tough spot, since it's a measure they traditionally oppose and Democrats historically support. "We can agree to disagree at times," Rep. Chris Collins (R-N.Y.), a key Trump ally in...
  • Big pharma is spending millions to fight limits on opioids like OxyContin, Vicodin and fentanyl

    09/27/2016 4:28:52 AM PDT · by Wolfie · 93 replies
    Vice News ^ | Sept. 18, 2016
    Big pharma is spending millions to fight limits on opioids like OxyContin, Vicodin and fentanyl The pharmaceutical industry has spent more than $880 million over the past decade to fight laws that would limit the availability of powerful opiods such as OxyContin, Vicodin and fentanyl in the United States, according to an investigation by the Associated Press and the Center for Public Integrity published Sunday. Often, these lobbying expenditures are funneled through groups like the American Cancer Society Cancer Action Network and other advocacy groups that represent the interests of patients with terminal cancer or chronic pain, whose conditions can...
  • Here's Everything We Know About The 'Secret Serum' Used To Treat An American With Ebola

    08/04/2014 1:08:30 PM PDT · by blam · 26 replies
    BI ^ | 8-4-2014 | Kevin Loria
    Kevin LoriaAugust. 4, 2014 Both of the Ebola-infected U.S. citizens in Liberia received a rare dose of what news reports called a "secret serum" to treat the virus before being transported to Emory University Hospital in Atlanta, according to a CNN report. And while some people do fight off the disease on their own, in the case of the two Americans, that experimental serum may have saved their lives. As Dr. Kent Brantly and missionary Nancy Writebol waited in a Liberian hospital, someone from the National Institutes of Health reached out to Samaritan's Purse, one of the two North Carolina-based...
  • Barry & Hillary—The Affirmative-Action Presidents

    08/04/2014 7:10:47 AM PDT · by CharlesOConnell
    The Washington Post ^ | 7/31/2014 | Sebastian Payne and Sean Sullivan
    “You’re likable enough, Hillary.” … Barack Obama made that remark in a televised debate ahead of the 2008 New Hampshire primaries. Back then, "more of the public preferred Obama over rival Sen. Hillary Clinton." [Polls, of course, aren't intended to INFLUENCE public opinion, they only REFLECT "Democratic" popular opinion. Psst! Anybody want to buy a bridge?] Read More…
  • Big Insurance was supposed to be "punished" by Obamacare; Big Insurance was behind it all the time

    07/24/2014 4:18:12 PM PDT · by CharlesOConnell · 17 replies
    American Chesterton Society Blog ^ | 2-20-2012 | Dale Ahlquist
    G.K. Chesterton’s Prophetic Look at National Health Care Dale Ahlquist | 2-20-2012 | American Chesterton Society Blogweb.archive.org/web/20130811135205/http://www.chesterton.org/2012/02/a-prophetic-look-at-national-health-care-2/G.K. Chesterton considered himself a member of the Liberal Party until 1912. As he would later say, he did not leave the Liberal Party. It left him. He believed in something called liberty, the idea that people should be able to make most decisions for themselves, especially the most basic and most important decisions, and not have such decisions made for them by anyone else, especially by the government. He believed, as a liberal, that the State’s role was to preserve liberty, not take...
  • Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures

    05/25/2014 7:19:26 PM PDT · by mgist · 11 replies
    pharmaceutical O nline ^ | 5/23/14 | Root
    Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures By Cyndi Root Masters Pharmaceutical issued a press release disputing the Food and Drug Administration’s (FDA) position on the raid at Master’s subsidiary RXTPL. The FDA and U.S. Marshalls went to RXTPL’s logistics facility in Fairfield, Ohio on Thursday, May 15, 2014. The government had a search warrant based on a November 2013 inspection at Ascend Laboratories, which showed the use of unapproved drugs. Masters says that RXTPL cooperated with the government in quarantining the drugs at the facility. However, Masters takes issue with the FDA press release that states that...
  • ObamaCare’s Crony Capitalism: Worse than We Thought

    11/11/2013 2:18:16 PM PST · by SJackson · 11 replies
    Commentary Magazine ^ | 11.07.2013 | Seth Mandel
    At times it seems like the sheer magnitude of bad news about ObamaCare can redound to its own benefit. It’s easy for individual pieces of bad news to get lost in the sea of failure that has characterized the Obama administration’s signature “achievement.” That might be the case with the most important story to appear about ObamaCare this week, from Tuesday’s edition of the New York Times. The paper reported that the Obama administration has ruled that the federal health-care program be exempted from the category of laws considered “federal health care programs.” Now, this is obviously dishonest: the federal...
  • Dirty medicine (Indian generic pharma fined $500m for fraudulent trials data)

    05/24/2013 4:21:02 AM PDT · by Zhang Fei · 2 replies
    Fortune ^ | May 15, 2013: 9:03 AM ET | Katherine Eban
    On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. (snip) His boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. (snip) Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then 35, an American-trained engineer and a naturalized U.S. citizen, had worked at Bristol-Myers Squibb (BMY)...